The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2026
Filed:
Apr. 29, 2020
Applicant:
Synlogic Operating Company, Inc., Cambridge, MA (US);
Inventor:
Eugene Antipov, Watertown, MA (US);
Assignee:
Synlogic Operating Company, Inc., Winchester, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/74 (2015.01); A61K 35/741 (2015.01); A61K 35/742 (2015.01); A61K 35/744 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61K 38/50 (2006.01); A61K 38/51 (2006.01); A61K 47/26 (2006.01); A61P 3/00 (2006.01); A61P 35/00 (2006.01); C12N 1/00 (2006.01); C12N 1/20 (2006.01); C12N 9/06 (2006.01); C12N 9/88 (2006.01); C12N 15/63 (2006.01); C12N 15/70 (2006.01); G01N 1/30 (2006.01); G01N 15/06 (2006.01); G01N 15/01 (2024.01); G01N 15/075 (2024.01);
U.S. Cl.
CPC ...
A61K 38/51 (2013.01); A61K 35/741 (2013.01); A61K 35/742 (2013.01); A61K 35/744 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 38/50 (2013.01); A61K 47/26 (2013.01); A61P 35/00 (2018.01); C12N 1/20 (2013.01); C12N 9/0022 (2013.01); C12N 9/88 (2013.01); C12N 15/635 (2013.01); C12N 15/70 (2013.01); C12Y 104/03002 (2013.01); C12Y 403/01024 (2013.01); G01N 1/30 (2013.01); G01N 15/06 (2013.01); C12N 2800/101 (2013.01); C12N 2820/002 (2013.01); C12N 2830/002 (2013.01); G01N 2001/302 (2013.01); G01N 15/01 (2024.01); G01N 15/075 (2024.01);
Abstract
Genetically engineered microorganisms, e.g., genetically engineered bacteria, compositions and formulations thereof, as well as methods for characterizing, dosing, and determining the activity of the bacteria, compositions, and formulations, e.g., using a live cell counting method are disclosed.